[Pancreatico-duodenal allotransplantation: experimental and clinical experience].
D058186:Acute Kidney Injury / Q000517:prevention & control; D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000601:surgery* / Q000628:therapy; D003925:Diabetic Angiopathies / Q000517:prevention & control; D003927:Diet, Diabetic; D004285:Dogs; D004386:Duodenum / Q000601:surgery*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007674:Kidney Diseases / Q000209:etiology; D016030:Kidney Transplantation; D008297:Male; D008722:Methods; D016035:Pancreas Transplantation; D010184:Pancreatic Extracts / Q000627:therapeutic use; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D007328:Insulin; D010184:Pancreatic Extracts; D001379:Azathioprine; D011241:Prednisone